Literature DB >> 11805322

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides.

Lidija Covic1, Amy L Gresser, Joyce Talavera, Steven Swift, Athan Kuliopulos.   

Abstract

Classical ligands bind to the extracellular surface of their cognate receptors and activate signaling pathways without crossing the plasma membrane barrier. We selectively targeted the intracellular receptor-G protein interface by using cell-penetrating membrane-tethered peptides. Attachment of a palmitate group to peptides derived from the third intracellular loop of protease-activated receptors-1 and -2 and melanocortin-4 receptors yields agonists and/or antagonists of receptor-G protein signaling. These lipidated peptides--which we have termed pepducins--require the presence of their cognate receptor for activity and are highly selective for receptor type. Mutational analysis of both intact receptor and pepducins demonstrates that the cell-penetrating agonists do not activate G proteins by the same mechanism as the intact receptor third intracellular loop but instead require the C-tail of the receptor. Construction of such peptide-lipid conjugates constitutes a new molecular strategy for the development of therapeutics targeted to the receptor-effector interface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805322      PMCID: PMC117359          DOI: 10.1073/pnas.022460899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Neurobiology. Receptors as kissing cousins.

Authors:  G Milligan
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

2.  PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit.

Authors:  S Swift; P J Sheridan; L Covic; A Kuliopulos
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.

Authors:  J Oosterom; K M Garner; W A Nijenhuis; W H Gispen; J P Burbach; G S Barsh; R A Adan
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

5.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation.

Authors:  M A Kjelsberg; S Cotecchia; J Ostrowski; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

Review 6.  G proteins: transducers of receptor-generated signals.

Authors:  A G Gilman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins).

Authors:  T Higashijima; S Uzu; T Nakajima; E M Ross
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

8.  Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Authors:  M Pfeiffer; T Koch; H Schröder; M Klutzny; S Kirscht; H J Kreienkamp; V Höllt; S Schulz
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

9.  Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation.

Authors:  T Okamoto; Y Murayama; Y Hayashi; M Inagaki; E Ogata; I Nishimoto
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

10.  The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.

Authors:  P Wikstrom; H Kirschke; S Stone; E Shaw
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

View more
  103 in total

1.  Development and characterization of pepducins as Gs-biased allosteric agonists.

Authors:  Richard Carr; Yang Du; Julie Quoyer; Reynold A Panettieri; Jay M Janz; Michel Bouvier; Brian K Kobilka; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2014-11-13       Impact factor: 5.157

Review 2.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

3.  Peptides derived from the third cytoplasmic loop of type 6 serotonin receptor as regulators of serotonin-sensitive adenylyl cyclase signaling system.

Authors:  A O Shpakov; I I Tarasenko; E A Shpakova
Journal:  Dokl Biochem Biophys       Date:  2010 Mar-Apr       Impact factor: 0.788

4.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

5.  Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.

Authors:  Paul A Gurbel; Kevin P Bliden; Susan E Turner; Udaya S Tantry; Martin G Gesheff; Travis P Barr; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01       Impact factor: 8.311

Review 6.  Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

Authors:  Madhu Chaturvedi; Justin Schilling; Alexandre Beautrait; Michel Bouvier; Jeffrey L Benovic; Arun K Shukla
Journal:  Trends Biochem Sci       Date:  2018-05-04       Impact factor: 13.807

7.  Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling.

Authors:  Sophie C Egea; Ian M Dickerson
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

8.  Studies of the molecular mechanisms of action of relaxin on the adenylyl cyclase signaling system using synthetic peptides derived from the LGR7 relaxin receptor.

Authors:  A O Shpakov; I A Gur'yanov; L A Kuznetsova; S A Plesneva; E A Shpakova; G P Vlasov; M N Pertseva
Journal:  Neurosci Behav Physiol       Date:  2007-09

Review 9.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

10.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.